Insulin Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Insulin Market to 2027 - Global Analysis and Forecasts by Product (Short Acting Insulin, Intermediate Acting Insulin, Long Acting Insulin, Premixed Insulin, Fast Acting Insulin); Indication (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Prediabetes) and Geography

Report Code: TIPRE00004051 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Insulin is hormone which is responsible for allowing glucose in the blood to enter cells. It helps in providing them with the energy to function. The lack of insulin is also responsible for the development of diabetes. Insulin is formed in the pancreas, the cells which produce insulin are known as islets and also determines the amount based on blood glucose levels in the body.

MARKET DYNAMICS
The insulin market is anticipated due to the key driving factors such as rising prevalence of the diabetes across the globe, rise in the generic production, rise in the advancement of pharmaceutical industries and others. The fastest growing prevalence of the diabetes across the globe and emerging regions for the healthcare industries are likely to grow the market during the forecast period.

MARKET SCOPE
The "Global Insulin Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of insulin market with detailed market segmentation by product and application and geography. The global insulin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading insulin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global insulin market is segmented on the basis of product and application. Based on the product the market is classified as short acting insulin, intermediate acting insulin, long acting insulin, premixed insulin, fast acting insulin. On the basis of the application the market is classified as type 1 diabetes, type 2 diabetes, gestational diabetes and prediabetes
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global insulin market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The insulin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Insulin market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the insulin market in these regions.

MARKET PLAYERS
The reports cover key developments in the Insulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Insulin market are anticipated to lucrative growth opportunities in the future with the rising demand for insulin market in the global market. Below mentioned is the list of few companies engaged in the Insulin market.

The report also includes the profiles of key insulin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Sanofi-Aventis
  • Novo Nordisk
  • Biocon
  • Eli Lilly
  • Wockhardt
  • Bioton S.A.
  • Julphar(Gulf Pharmaceutical Industries)
  • Pirmal Healthcare
  • US Vitamins Limited
  • Abbott
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Insulin Market - By Product
1.3.2 Insulin Market - By Indication
1.3.3 Insulin Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. INSULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INSULIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INSULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. INSULIN - GLOBAL MARKET OVERVIEW
6.2. INSULIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INSULIN MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SHORT ACTING INSULIN
7.3.1. Overview
7.3.2. Short Acting Insulin Market Forecast and Analysis
7.4. INTERMEDIATE ACTING INSULIN
7.4.1. Overview
7.4.2. Intermediate Acting Insulin Market Forecast and Analysis
7.5. LONG ACTING INSULIN
7.5.1. Overview
7.5.2. Long Acting Insulin Market Forecast and Analysis
7.6. PREMIXED INSULIN
7.6.1. Overview
7.6.2. Premixed Insulin Market Forecast and Analysis
7.7. FAST ACTING INSULIN
7.7.1. Overview
7.7.2. Fast Acting Insulin Market Forecast and Analysis
8. INSULIN MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. TYPE 1 DIABETES
8.3.1. Overview
8.3.2. Type 1 Diabetes Market Forecast and Analysis
8.4. TYPE 2 DIABETES
8.4.1. Overview
8.4.2. Type 2 Diabetes Market Forecast and Analysis
8.5. GESTATIONAL DIABETES AND PREDIABETES
8.5.1. Overview
8.5.2. Gestational Diabetes and Prediabetes Market Forecast and Analysis
9. INSULIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Insulin Market Overview
9.1.2 North America Insulin Market Forecasts and Analysis
9.1.3 North America Insulin Market Forecasts and Analysis - By Product
9.1.4 North America Insulin Market Forecasts and Analysis - By Indication
9.1.5 North America Insulin Market Forecasts and Analysis - By Countries
9.1.5.1 United States Insulin Market
9.1.5.1.1 United States Insulin Market by Product
9.1.5.1.2 United States Insulin Market by Indication
9.1.5.2 Canada Insulin Market
9.1.5.2.1 Canada Insulin Market by Product
9.1.5.2.2 Canada Insulin Market by Indication
9.1.5.3 Mexico Insulin Market
9.1.5.3.1 Mexico Insulin Market by Product
9.1.5.3.2 Mexico Insulin Market by Indication
9.2. EUROPE
9.2.1 Europe Insulin Market Overview
9.2.2 Europe Insulin Market Forecasts and Analysis
9.2.3 Europe Insulin Market Forecasts and Analysis - By Product
9.2.4 Europe Insulin Market Forecasts and Analysis - By Indication
9.2.5 Europe Insulin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Insulin Market
9.2.5.1.1 Germany Insulin Market by Product
9.2.5.1.2 Germany Insulin Market by Indication
9.2.5.2 France Insulin Market
9.2.5.2.1 France Insulin Market by Product
9.2.5.2.2 France Insulin Market by Indication
9.2.5.3 Italy Insulin Market
9.2.5.3.1 Italy Insulin Market by Product
9.2.5.3.2 Italy Insulin Market by Indication
9.2.5.4 Spain Insulin Market
9.2.5.4.1 Spain Insulin Market by Product
9.2.5.4.2 Spain Insulin Market by Indication
9.2.5.5 United Kingdom Insulin Market
9.2.5.5.1 United Kingdom Insulin Market by Product
9.2.5.5.2 United Kingdom Insulin Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Insulin Market Overview
9.3.2 Asia-Pacific Insulin Market Forecasts and Analysis
9.3.3 Asia-Pacific Insulin Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Insulin Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Insulin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Insulin Market
9.3.5.1.1 Australia Insulin Market by Product
9.3.5.1.2 Australia Insulin Market by Indication
9.3.5.2 China Insulin Market
9.3.5.2.1 China Insulin Market by Product
9.3.5.2.2 China Insulin Market by Indication
9.3.5.3 India Insulin Market
9.3.5.3.1 India Insulin Market by Product
9.3.5.3.2 India Insulin Market by Indication
9.3.5.4 Japan Insulin Market
9.3.5.4.1 Japan Insulin Market by Product
9.3.5.4.2 Japan Insulin Market by Indication
9.3.5.5 South Korea Insulin Market
9.3.5.5.1 South Korea Insulin Market by Product
9.3.5.5.2 South Korea Insulin Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Insulin Market Overview
9.4.2 Middle East and Africa Insulin Market Forecasts and Analysis
9.4.3 Middle East and Africa Insulin Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Insulin Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Insulin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Insulin Market
9.4.5.1.1 South Africa Insulin Market by Product
9.4.5.1.2 South Africa Insulin Market by Indication
9.4.5.2 Saudi Arabia Insulin Market
9.4.5.2.1 Saudi Arabia Insulin Market by Product
9.4.5.2.2 Saudi Arabia Insulin Market by Indication
9.4.5.3 U.A.E Insulin Market
9.4.5.3.1 U.A.E Insulin Market by Product
9.4.5.3.2 U.A.E Insulin Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Insulin Market Overview
9.5.2 South and Central America Insulin Market Forecasts and Analysis
9.5.3 South and Central America Insulin Market Forecasts and Analysis - By Product
9.5.4 South and Central America Insulin Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Insulin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Insulin Market
9.5.5.1.1 Brazil Insulin Market by Product
9.5.5.1.2 Brazil Insulin Market by Indication
9.5.5.2 Argentina Insulin Market
9.5.5.2.1 Argentina Insulin Market by Product
9.5.5.2.2 Argentina Insulin Market by Indication
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. INSULIN MARKET, KEY COMPANY PROFILES
11.1. SANOFI-AVENTIS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. NOVO NORDISK
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOCON
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. WOCKHARDT
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOTON S.A.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JULPHAR(GULF PHARMACEUTICAL INDUSTRIES)
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PIRMAL HEALTHCARE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. US VITAMINS LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ABBOTT
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Sanofi-Aventis
2. Novo Nordisk
3. Biocon
4. Eli Lilly
5. Wockhardt
6. Bioton S.A.
7. Julphar(Gulf Pharmaceutical Industries)
8. Pirmal Healthcare
9. US Vitamins Limited
10. Abbott